CoChat

Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST)

Open access
Stott, David J., Gussekloo, Jacobijn, Kearney, Patricia M., Rodondi, Nicolas, Westendorp, Rudi G. J., Mooijaart, Simon, Kean, Sharon, Quinn, Terence J., Sattar, Naveed, Hendry, Kirsty, Du Puy, Robert, Den Elzen, Wendy P. J., Poortvliet, Rosalinde K. E., Smit, Jan W. A., Jukema, J. Wouter, Dekkers, Olaf M., Blum, Manuel, Collet, Tinh-Hai, McCarthy, Vera, Hurley, Caroline, Byrne, Stephen, Browne, John, Watt, Torquil, Bauer, Douglas, Ford, Ian · 2017 · BMC Endocrine Disorders
Cited by 46

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Subclinical hypothyroidism (SCH) is a common condition in elderly people, defined as elevated serum thyroid-stimulating hormone (TSH) with normal circulating free thyroxine (fT4). Evidence is lacking about the effect of thyroid hormone treatment. We describe the protocol of a large randomised controlled trial (RCT) of Levothyroxine treatment for SCH. METHODS: Participants are community-dwelling subjects aged ≥65 years with SCH, diagnosed by elevated TSH levels (≥4.6 and ≤19.9 mU/L) on a minimum of two measures ≥ three months apart, with fT4 levels within laboratory reference range. The study is a randomised double-blind placebo-controlled parallel group trial, starting with levothyroxine 50 micrograms daily (25 micrograms in subjects <50Kg body weight or known coronary heart disease) with titration of dose in the active treatment group according to TSH level, and a mock titration in the placebo group. The primary outcomes are changes in two domains (hypothyroid symptoms and fatigue / vitality) on the thyroid-related quality of life questionnaire (ThyPRO) at one year. The study has 80% power (at p = 0.025, 2-tailed) to detect a change with levothyroxine treatment of 3.0% on the hypothyroid scale and 4.1% on the fatigue / vitality scale with a total target sample size of 750 patients. Secondary outcomes include general health-related quality of life (EuroQol), fatal and non-fatal cardiovascular events, handgrip strength, executive cognitive function (Letter Digit Coding Test), basic and instrumental activities of daily living, haemoglobin, blood pressure, weight, body mass index and waist circumference. Patients are monitored for specific adverse events of interest including incident atrial fibrillation, heart failure and bone fracture. DISCUSSION: This large multicentre RCT of levothyroxine treatment of subclinical hypothyroidism is powered to detect clinically relevant change in symptoms / quality of life and is likely to be highly influential in guiding treatment of this common condition. TRIAL REGISTRATION: Clinicaltrials.gov NCT01660126 ; registered 8th June 2012.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12902-017-0156-8

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 46

Metadata

Authors
Stott, D. J., Gussekloo, J., Kearney, P. M., Rodondi, N., Westendorp, R. G. J., Mooijaart, S., Kean, S., Quinn, T. J., Sattar, N., Hendry, K., Du Puy, R., Den Elzen, W. P. J., Poortvliet, R. K. E., Smit, J. W. A., Jukema, J. W., Dekkers, O. M., Blum, M., Collet, T.-H., McCarthy, V., Hurley, C., Byrne, S., Browne, J., Watt, T., Bauer, D., & Ford, I.
Venue
BMC Endocrine Disorders
Published
2017-02-03
Volume
17
Issue
1
Pages
6-6
ISSN
1472-6823 (ISSN-L)
OpenAlex
W2583713299
Cited by
46
References
12
FWCI
4.08
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST). https://app.cochat.ai/papers/10.1186/s12902-017-0156-8
The paper
Stott, D. J., Gussekloo, J., Kearney, P. M., Rodondi, N., Westendorp, R. G. J., Mooijaart, S., Kean, S., Quinn, T. J., Sattar, N., Hendry, K., Du Puy, R., Den Elzen, W. P. J., Poortvliet, R. K. E., Smit, J. W. A., Jukema, J. W., Dekkers, O. M., Blum, M., Collet, T.-H., McCarthy, V., . . . Ford, I. (2017). Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST). BMC Endocrine Disorders. https://doi.org/10.1186/s12902-017-0156-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.